A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL STUDY TO EVALUATE COMPARATIVE CLINICAL EFFICACY AND SAFETY OF BHC9619CP TURMERIC EXTRACT IN JOINT HEALTH
*Dr. Sneha V. P., Madhu Krishnamani, Mr. Gaurav Soni and Dr. S. G. Kinni
Osteoarthritis (OA) is a chronic condition that impacts quality of life and functionality for which patients often seek dietary supplements to provide some relief. The purpose of this double-blind, placebo-controlled clinical trial was to assess the safety and efficacy of BHC9619CP Turmeric Extract on pain, stiffness, physical activity and general health and well-being in 30 adults with OA randomized into active intervention (n = 15) or placebo (n = 15) groups. Outcomes were assessed periodically for 56 days, including the Western Ontario McMaster Osteoarthritis Index (WOMAC), the Visual Analogue Scale (VAS) for pain, and safety. Normalized analysis (improvement over baseline) showed that significant alleviation of pain was observed in active intervention group. Results also revealed that the treatment improved the physical function of the patients by significantly reducing pain and improving stiffness as well as physical activity. The Product was also found to be safe in this study. In conclusion, daily consumption of BHC9619CP Turmeric Extract significantly alleviates pain and improvement in stiffness and physical activity over the treatment period of 56 days. BHC9619CP Turmeric Extract may offer a safe option for relief from symptoms and increased mobility for those with OA.
Keywords: Curcuma longa; turmeric; joint health; efficacy; osteoarthritis; safety.
[Full Text Article]